News

Find out about the latest developments in our dynamic translational research

Understanding mutation progression to detect ovarian cancer earlier

Nina Wietek from the Ahmed lab is investigating fallopian tube tissue to see what we can understand about precancerous mutations in the tissue from which ovarian cancers develops.

New study investigates how growth factors in our gut could initiate cancer

Dr Francesco Boccellato is investigating the mechanisms of tissue regulation in the healthy stomach and in a pre-cancerous condition known as atrophic gastritis. This may help to identify those who may have cancer, as well as find new ways to prevent cancer from progressing
Schematic drawing of the DNA double helix

New method for cost-effective genome-wide DNA methylation analysis

Dr Chunxiao Song’s team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.

Using Herpesvirus to fight cancer

The Seymour lab at the Department of Oncology, University of Oxford, has published a new paper investigating the use of oncolytic herpes virus-1 as a vector to augment immunotherapy in cancer

Oxford success at the early detection sandpit on pancreatic cancer

Professor Eric O’Neill and Dr Pui San Tan receive funding as part of teams applying novel approaches for the early detection of pancreatic cancer.

Further funding secured to hunt out cancer using innovative radiotherapy techniques

Initial success leads to new award for Oxford researcher pushing forward new cancer-hunting radiotherapy.

Artwork donated to Oxford ward for patients undergoing cancer clinical trials

A generous donation by artist Lida Sherafatmand has seen three prints installed into the Early Phase Clinical Trials Unit at the Churchill Hospital in Oxford.

T-cell landscape mapping identifies new targets for pancreatic cancer immunotherapy

Through analysis of T-cell populations, Oxford pancreatic researchers identify novel therapeutic opportunities in pancreatic cancer patients
An animation showing a dial with green, amber and red risk levels for myeloma

New clinical prediction tools for myeloma

Dr Constantinos Koshiaris has developed clinical prediction models for use in primary care with the aim of accelerating myeloma diagnoses.

Oxford at the American Association for Cancer Research Annual Meeting

Oxford researchers are out in force at next week’s AACR Annual Meeting, check out what they’ll be talking about

Early Detection Award for research into the clinical application of single cell genomics

Dr Onima Chowdhury will investigate the clinical application of single cell sequencing for early diagnosis and response prediction in myelodysplastic syndromes.
Doctor looking at skin

Higher testosterone levels in men linked to greater melanoma risk

New research from Dr Eleanor Watts at the Nuffield Department of Population Health has found this association for the first time